The company adds it has spent $58.7M in Q1 to buy back 1.4M shares (implied avg. purchase price of $41.92). After factoring those purchases, WebMD now has $51M available under its authorization.
WebMD spent $211.3M on buybacks in Q4. It ended 2013 with $855M in cash, and $952M in debt.